weight · loss

Amlexanox

FDA: FDA-approved

Amlexanox is an anti-inflammatory compound that adds metabolic resilience by addressing leptin resistance and fat partitioning. Originally FDA-approved for treating canker sores, it has been repurposed in peptide protocols for its metabolic and anti-inflammatory properties. Anti-inflammatory agent that helps with leptin resistance and fat partitioning. Inhibits IKKe and TBK1, two kinases involved in inflammation and energy storage. Adds metabolic resilience when combined with other fat-loss peptides. Helps the body respond better to weight loss signals. - Anti-inflammatory metabolic support - Leptin resistance improvement - Fat partitioning optimization - Metabolic resilience - Enhanced response to diet and exercise interventions - Standard:

This content is for educational and research purposes only. VialBase does not provide medical advice. Consult a healthcare professional before using any peptide.

Molecular weight —

Half-life —

CAS number —

Route —

Stacks containing Amlexanox

Fasted Burner

Tesamorelin + Amlexanox + AOD-9604

What bloodwork do I need?

Reference ranges are general guidelines. Consult your physician for interpretation.

PRE-CYCLE

CMP
CBC
Lipid Panel
Fasting Glucose
Fasting Insulin
HbA1c
CRP

DURING CYCLE

CMP
Fasting Glucose
CRP

POST-CYCLE

CMP
Lipid Panel
Fasting Glucose
HbA1c

Safety & Regulatory Status

FDA STATUS FDA-approved

Regulatory status for Amlexanox may change. Verify current status with your jurisdiction before use. This is not legal or medical advice.